
|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Drug Safety Fears May Limit Reimporting and Shape R&D
Author(s)Jill Wechsler
Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.
Advertisement
Articles in this issue
almost 21 years ago
Correcting the Coursealmost 21 years ago
February 2005almost 21 years ago
Good Work and True: USP Prepares for Convention 2005almost 21 years ago
Contract Manufacturers Getting Squeezedalmost 21 years ago
In the Spotlight-February 2005almost 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Linealmost 21 years ago
In Defense of USP Singlet TestingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
Why Investment Strategies Matter for Advancing Pharmaceutical Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
5





